金年会|金年会·jinnian(金字招牌)诚信至上
About us
Our Values
Development Milestone
Products
Product List for API
Recommended API
Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
中文版
旧版入口
About us
News
Investor Relation
Products
Contract Manufacturing
Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Reply Slip for the Second Extraordinary General Meeting for the Year 2024
2024-11-13
Proxy Form for the Second Extraordinary General Meeting for the Year 2024
2024-11-13
Notice of Extraordinary General Meeting
2024-11-13
(1) Continuing Connected Transactions; And(2) Notice of Extraordinary General Meeting
2024-11-13
Overseas Regulatory Announcement-Announcement on Febuxostat Tablets Having Obtained the Drug Registration Certificate
2024-11-11
Announcement on Calcium Gluconate Injection Passing the Generics Consistency Evaluation
2024-11-05
Announcement on Pentazocine Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs
2024-11-04
Announcement on Drugs of Wholly-owned Subsidiary Passing the Generics Consistency Evaluation
2024-11-04
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2024
2024-11-01
Change of Branch Share Registrar and Transfer Office in Hong Kong
2024-10-29
<
1
2
3
4
5
6
7
...
>
友情链接:
jinnianhui金年会首页
beat365亚洲体育在线官网
美狮贵宾会
鸿运平台官网登录入口
金年会金字招牌信誉至上